Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial : The Lancet

Links shared publicly online about this topic.

  • 85
    total visits

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial : The Lancet

thelancet.com —

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. By - Prof Elisabe...

View full resource at thelancet.com

Tags: Pelvic Inflammatory Disease, Cancer, Cancer Medication, Ovarian Cancer, Disease and Condition, Women's Health, Taxol, disease

  • Share

Most Recently Shared on August 11, 2011 at 11:39 pm By:

oncopharm Ruth Stephen

in older non small cell lung cancer patients platinum based doublet chemotherpay is superior to monotherapy http://t.co/vPAjXiV

9 months ago...

Reply

Retweet

Favorite

Also Shared By:

The Lancet The Lancet

Miriam E. Tucker Miriam E. Tucker

eyeonfda eyeonfda

Advertisement